Occlusion is the complete or partial closure or blockage of any body channel, vessel, duct, or opening, resulting in impaired or absent flow of blood, fluid, secretions, or air through that structure. It is distinguished from stenosis, which denotes a narrowing that reduces but does not eliminate luminal patency, and from thrombosis, which is a mechanism-specific term implying in-situ clot formation as the cause of blockage — whereas occlusion describes the state of closure regardless of cause.
The underlying mechanism may be thrombotic, embolic (traveling particulate matter lodging in a vessel), compressive , vasospastic, inflammatory , or structural/anatomical. Occlusion may be physiological — as in dental occlusion or therapeutic lid occlusion in amblyopia management — or pathological, as in central retinal artery occlusion causing acute painless monocular vision loss, or ureteral occlusion producing hydronephrosis. Clinically relevant subtypes most encountered in inpatient coding include retinal artery occlusion (H34.10-H34.239), retinal vein occlusion (H34.811-H34.839), nasolacrimal duct obstruction (H04.551-H04.559), Eustachian tube obstruction (H68.101-H68.139), and urinary tract obstruction (N13.0-N13.5, N32.0). Occlusion is most commonly confused with obstruction — a broader term used interchangeably in clinical notes but mapped to distinctly different ICD-10-CM categories by site and etiology; when documentation uses “obstruction,” the coder must identify the specific anatomical location and cause to assign the most accurate code.
”to close,” “to shut,” “to bar” — -clud- is the present-stem form; -clus- is the perfect participial stem used in nouns and adjectives derived from the past passive
The word entered English in the 1640s as occlusion (noun), borrowed from Latin occlusionem (accusative of occlusio), from occludere — literally “a shutting against” or “a closing off.” The adjectival form occlusive appeared later in the 1800s in physiological and clinical writing. The root claudere (“to close, to shut”) connects occlusion to the entire -clud- / -clus- root family: claudication (claudicare → “to limp” — from arterial insufficiency causing ischemic limb pain), exclusion (ex- + cludere → “to shut out”), seclusion (se- + cludere → “to shut apart”), inclusion (in- + cludere → “to shut in”), and preclusion (prae- + cludere → “to shut before, to prevent”). The assimilated prefixoc- (from ob-) is highly productive in anatomical and medical language, appearing in occlusion (vascular/ductal), occlusal (dental), and occult (hidden — literally “shut away from sight”), as in occult blood — blood “closed off” from visible detection and requiring chemical testing to identify.
🔀 ALIASES / ALTERNATE TERMS
Occlusive(adjective form — common clinical collocations: “occlusive arterial disease,” “occlusive dressing,” “occlusive thrombus”)
Blockage(lay term frequently used in patient-facing documentation and discharge summaries; not a directly codeable term — must be mapped to the specific anatomical site and etiology for ICD-10-CM assignment)
Obstruction(clinical synonym used interchangeably in provider documentation; coded under different ICD-10-CM categories by site — e.g., N13.x for urinary tract, H68.1x for Eustachian tube, H04.55x for nasolacrimal duct; triggers coder review for site and etiology specificity)
Occlude(verb form — “the artery occluded acutely”; “the stent occluded postoperatively”)
CRAO(Central Retinal Artery Occlusion — acute, painless monocular vision loss from closure of the central retinal artery; H34.11-H34.13 by laterality; ophthalmologic emergency with poor visual prognosis)
CRVO(Central Retinal Vein Occlusion — engorgement and flame hemorrhage of the entire retinal venous system from occlusion of the central retinal vein; H34.811-H34.819)
BRVO(Branch Retinal Vein Occlusion — segmental venous occlusion affecting one quadrant of the retina at an arteriovenous crossing; most common retinal vascular disorder; H34.831-H34.839)
BRAO(Branch Retinal Artery Occlusion — typically embolic; affects a retinal arterial tributary causing sector field loss; H34.231-H34.239)
Thrombotic occlusion(mechanism subtype — occlusion caused by in-situ thrombus formation; often associated with atherosclerosis or hypercoagulable states)
Embolic occlusion(mechanism subtype — caused by a traveling embolus lodging in a smaller vessel; e.g., Hollenhorst plaque at a retinal arteriolar bifurcation; H34.211-H34.219)
Vasospastic occlusion(mechanism subtype — transient functional occlusion from arterial smooth muscle contraction; seen in Raynaud phenomenon and migraine-associated retinal occlusion)
Functional obstruction(subtype — impaired flow without a fixed structural blockage, e.g., neurogenic bladder-related urinary retention; contrasted with mechanical obstruction which has a physical cause and distinct coding pathway)
🔗 RELATED TERMS
Stenosis — partial narrowing of a vessel or passage without complete closure; lumen remains patent but reduced; distinguished from occlusion by the presence of residual flow; coded separately depending on site (e.g., N13.5 for ureteral stricture without hydronephrosis, H04.551-H04.559 for nasolacrimal duct stenosis)
Thrombosis — mechanism-specific term for occlusion caused by in-situ clot formation; a subset of occlusion etiologies; when thrombosis is the documented cause of a retinal vascular occlusion, the retinal code (H34.x) is sequenced as the principal diagnosis, not a thrombosis code
Embolism — traveling particulate material (thrombus fragment, cholesterol crystal, air, fat) that lodges distally and causes occlusion; Hollenhorst plaque (H34.211-H34.219) is the canonical ophthalmic example, typically originating from carotid artery atherosclerosis
Ischemia — tissue-level oxygen deprivation resulting from vascularocclusion; the immediate downstream consequence; when ischemia is documented as a sequela, the underlying occlusion is sequenced as the principal diagnosis
infarction — irreversible tissue necrosis from sustained vascular occlusion; the end-stage consequence; central retinal artery occlusion (H34.1x) frequently results in permanent macular infarction if not treated within hours of onset
Recanalization — restoration of luminal flow through a previously occluded vessel, either spontaneously, pharmacologically (thrombolytics, anti-VEGF), or procedurally (thrombectomy, stenting, balloon dilation]])
Hydronephrosis — dilation of the renal pelvis and calyces caused by outflow obstruction; a direct structural consequence of ureteral or ureteropelvic junction occlusion; coded at N13.0-N13.39 with specificity by documented cause
Atherosclerosis — chronic lipid-driven arterial wall disease; the most common underlying etiology of arterial occlusion; coded as a principal or additional diagnosis when documented as the cause of the occlusive event
Hollenhorst plaque — cholesterol crystal embolus lodging at a retinal arteriolar bifurcation, causing BRAO or transient monocular vision loss; coded H34.211-H34.219; a key intraocular finding that prompts carotid duplex and cardiac workup to identify the embolic source
Dacryocystitis — infection and inflammation of the lacrimal sac secondary to nasolacrimal duct obstruction (H04.55x); frequently coded together with or as a consequence of the ductal occlusion diagnosis (H04.301-H04.313 by laterality and acuity)
Ureteral stent — primary procedural intervention for ureteral occlusion/obstruction; coded CPT 52332 (cystourethroscopic insertion) or 50393 (percutaneous antegrade); relieves obstruction and prevents hydronephrotic progression pending definitive repair
Fluorescein angiography — primary diagnostic imaging modality for evaluating retinal vascular occlusions; documents areas of capillary non-perfusion, leakage, disc collaterals, and neovascularization; CPT 92235 (FA with interpretation and report)
CODING CORNER
🏥 ICD-10-CM CODES
Retinal Artery Occlusion — Central (H34.1x — 6th Character Laterality Required)
Scanning computerized ophthalmic diagnostic imaging, retina, with interpretation and report (OCT; monitors macular edema in CRVO/BRVO and documents ischemic zone extent)
Indocyanine-green angiography with interpretation and report (adjunct to fluorescein angiography; superior for choroidal and posterior pole perfusion assessment)
Destruction of localized lesion of retina, 1 session; laser photocoagulation for focal ischemic complications and neovascularization secondary to branch RVO
Treatment of extensive or progressive retinopathy, 1 session; pan-retinal photocoagulation for neovascularization and vitreous hemorrhage from ischemic CRVO
68810
Probing of nasolacrimal duct, with or without irrigation (nasolacrimal duct obstruction; not requiring general anesthesia)
68811
Probing of nasolacrimal duct, with or without irrigation; requiring general anesthesia (pediatric nasolacrimal duct obstruction; infant cases)
68815
Probing of nasolacrimal duct; with insertion of tube or stent (recurrent or failed initial probing; silicone bicanalicular intubation)
68816
Probing of nasolacrimal duct with balloon catheter dilation (adjunct to probing for resistant stenosis; typically performed under general anesthesia)
Cystourethroscopy with insertion of indwelling ureteral stent (relief of ureteral obstruction; temporary or long-term decompression)
52341
Cystourethroscopy with treatment of ureteral stricture; ureter (endoscopic balloon dilation of ureteral occlusion via retrograde approach)
50387
Removal and replacement of externally accessible nephroureteral catheter (exchange for ureteral obstruction management; fluoroscopic guidance included)
⚠️ Coding Note: All retinal vascular occlusion codes (H34.1x-H34.8x) require eye laterality at the 5th or 6th character — “unspecified eye” codes are valid but payers including Medicare and BCBS of Wisconsin typically require laterality specificity for clean claims and anti-VEGF medical necessity review; always initiate a query when laterality is absent from provider documentation. Sequencing follows standard etiology-manifestation logic: when hypertension, diabetes, or a hypercoagulable state is the documented etiology of a retinal occlusion, the occlusion (H34.x) is the principal diagnosis and the underlying condition sequences as an additional code — do not reverse.
A high-yield undercoding risk on inpatient profee claims is collapsing BRVO and CRVO into a single unspecified RVO code: documentation containing “branch RVO,” “tributary occlusion,” or “BRVO” must be coded H34.831-H34.839 — a clinically and reimbursement-distinct subcategory from central RVO (H34.811-H34.819); when documentation states only “retinal vein occlusion” without central vs. branch distinction, a physician query is warranted and should cite the treatment-planning implications. For ureteral obstruction with concurrent hydronephrosis, code specificity at N13.0-N13.39 hinges on documented cause — unspecified hydronephrosis (N13.30) is a common undercoding pattern when etiology is documented elsewhere in the record but not explicitly linked in the assessment; review the H&P, operative note, and radiology report before defaulting to unspecified. Postprocedural urethral stricture (N99.110-N99.116) requires anatomical site specificity — when the urologist documents only “urethral stricture after TURP” or “post-catheterization stricture,” query for stricture location (meatal, bulbous, membranous, fossa navicularis) to reach the most specific N99.11x code and support downstream treatment authorization for urethrotomy or urethroplasty.
A Word From MedlinePlus:
Acute arterial occlusion of the kidney is a sudden, severe blockage of the artery that supplies blood to the kidney.
Causes
The kidneys need a good blood supply. The main artery to the kidney is called the renal artery. Reduced blood flow through the renal artery can hurt kidney function. A complete blockage of blood flow to the kidney can often result in permanent kidney failure.
Acute arterial occlusion of the renal artery can occur after injury or trauma to the abdomen, side, or back. Blood clots that travel through the bloodstream (emboli) can lodge in the renal artery. Pieces of plaque from the walls of the arteries can come loose (on their own or during a medical procedure that affects an artery). This debris can block the main kidney artery or one of the smaller vessels.
The risk of renal artery blockages increases in people who have certain heart disorders, which make them likely to form blood clots. These include mitral stenosis and atrial fibrillation.
A narrowing of the renal artery is called renal artery stenosis. This condition increases the risk of a sudden blockage.
Symptoms
You may not have symptoms when one kidney does not function because the second kidney can filter the blood. However, high blood pressure (hypertension) may come on suddenly and be difficult to control.
If your other kidney is not working fully, blockage of the renal artery may cause symptoms of acute kidney failure. Other symptoms of acute arterial occlusion of the renal artery include:
Some people do not need treatment. Blood clots may get better on their own over time.
You may have treatment to open the artery if the blockage is discovered quickly or it is affecting your only working kidney. Treatment to open the artery may include:
Clot-dissolving medicines (thrombolytics)
Medicines that prevent the blood from clotting (anticoagulants), such as warfarin
Surgical repair of the renal artery
Insertion of a tube (catheter) into the renal artery to open the blockage
You may need temporary dialysis to treat acute kidney failure. Medicines to lower cholesterol may be needed if the blockage is due to clots from plaque buildup in the arteries.
Outlook (Prognosis)
Damage caused by arterial occlusion may go away. However, in most cases, it is permanent.
If only one kidney is affected, the healthy kidney may take over filtering the blood and producing urine. If you have only one working kidney, arterial occlusion leads to acute kidney failure. This can develop into chronic kidney disease or failure.
You feel sudden, severe pain in the back, flank, or abdomen
Get emergency medical help right away if you have symptoms of arterial occlusion and have only one working kidney.
Prevention
In many cases, the disorder is not preventable. The most important way to reduce your risk is to stop smoking.
People at risk for developing blood clots may need to take anti-clotting medicines. Taking steps to control diseases related to atherosclerosis (hardening of the arteries) may reduce your risk.
Crystal's Coder Hub
